DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000ME9Z5S4

Market Closed - Börse Stuttgart 17:12:51 31/05/2024 BST
3.46 EUR +4.22% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-8.22%
1 month-8.22%
Date Price Change
31/05/24 3.46 +4.22%
30/05/24 3.32 +2.47%
29/05/24 3.24 +45.29%
28/05/24 2.23 -7.08%
24/05/24 2.4 -4.00%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 05:12 pm

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9Z5S
ISINDE000ME9Z5S4
Date issued 08/03/2024
Strike 90 $
Maturity 20/09/2024 (112 Days)
Parity 1 : 1
Emission price 2.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.78
Lowest since issue 2.23
Spread 0.08
Spread %2.35%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
79.98 USD
Average target price
90.35 USD
Spread / Average Target
+12.97%
Consensus